5G Company Pumps After 9,653% Revenue Increase

CarMax Dips Following Lackluster Earnings Report ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Good morning Wake-Up Watchlisters! While you're sipping coffee you'll see US stock futures slumped on Thursday after a relief rally failed. Recession jitters are back as investors are worried by the Bank of England's bond-buying move. While we always focus on positivity at Monument Traders Alliance – these recent market developments have us worried. So we're looking at other ways you can protect your money as recession fears loom. Click here to see why you should move your cash into this $3 investment by October 7th. Windtree Therapeutics (Nasdaq: WINT) Windtree Therapeutics is up 49.60% premarket after the biotechnology company reported positive results in its Phase 2 istatroxime study in early cardiogenic shock. The findings were published in European Journal of Heart Failure and demonstrated that isatroxime can rapidly and significantly improve blood pressure and key parameters of cardiac function in a failing heart. Biotech stocks have potential for massive swings, and we recently closed a trade on a medical stock in The War Room for a 74% gain – and it all happened in just 2 trading days! Click here to see that trade. Bargain in Today's Market (SHOCKING) This "World's Most Admired" company's stock would be a bargain at $50... Today it's just under $2! Plus... a key announcement in December, could send it ROCKETING skyward... Click Here Now (Before It's Too Late!) CarMax (NYSE: KMX) CarMax is down 10.32% premarket after the company reported less-than-stellar second quarter results. Total wholesale units decreased 15.1% with gross profit per unit of $881, a decrease of $124 per unit. There were 342,731 vehicles bought, down 8.1% versus last year's second quarter. Net earnings per diluted share came in at $0.79, down from $1.72 a year ago. Axcella Health (Nasdaq: AXLA) Axcella Health is up 23.70% premarket after announcing positive intermin data from a phase2b study of AXA1125 for its treatment of NASH (non alcoholic steatohepatitis). At 24 weeks there were statistically significant improvements in the liver stiffness measurement compared to placebo. Datasea (NYSE: DTSS) Datasea is up 11.76% premarket after the digital technology company reported strong growth. It launched 5G messaging solutions, which helped revenue explode. Overall revenue was $17,080,911, compared to just $175,138 last year, marking an increase of 9,653%. The company also expects to have more sources of revenue in the future, including acoustic intelligence. Big swings in the market happen for a reason. And one way you can tell a stock will swing up or down is by looking at insider buying (the legal kind). Our Head Fundamental Tactician Karim Rahemtulla shows you how to monitor insider buying in a way that could lead to 2,250%+ gains. Click here to see how the Insider Matrix works. Did Biden Sleepwalk Us Into America's Reckoning? Starting October 7, we could find ourselves in the worst financial crisis in 50 years. The only question: Are you prepared? Click Here for Urgent Briefing Monument Traders Alliance   You are receiving this email because you subscribed to Trade of the Day Wake-Up Watchlist. To unsubscribe from Trade of the Day Wake-Up Watchlist, click here. Questions? Check out our FAQs. Trying to reach us? Contact us here. Please do not reply to this email as it goes to an unmonitored inbox. To cancel by mail or for any other subscription issues, write us at: Trade of the Day | 14 West Mount Vernon Place | Baltimore, MD 21201 North America: 1.800.507.1399 | International: +1.443.353.4977 Website | Privacy Policy Keep the emails you value from falling into your spam folder. Whitelist Trade of the Day. © 2022 Monument Traders Alliance, LLC | All Rights Reserved Nothing published by Monument Traders Alliance should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized investment advice. We expressly forbid our writers from having a financial interest in their own securities recommendations to readers. All of our employees and agents must wait 24 hours after online publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended by Monument Traders Alliance should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.